Fast Inhibition of Glutamate-Activated Currents by Caffeine by Vyleta, Nicholas P. & Smith, Stephen M.
Fast Inhibition of Glutamate-Activated Currents by
Caffeine
Nicholas P. Vyleta, Stephen M. Smith*
Division of Pulmonary & Critical Care Medicine, Oregon Health & Science University, Portland, Oregon, United States of America
Abstract
Background: Caffeine stimulates calcium-induced calcium release (CICR) in many cell types. In neurons, caffeine stimulates
CICR presynaptically and thus modulates neurotransmitter release.
Methodology/Principal Findings: Using the whole-cell patch-clamp technique we found that caffeine (20 mM) reversibly
increased the frequency and decreased the amplitude of miniature excitatory postsynaptic currents (mEPSCs) in neocortical
neurons. The increase in mEPSC frequency is consistent with a presynaptic mechanism. Caffeine also reduced exogenously
applied glutamate-activated currents, confirming a separate postsynaptic action. This inhibition developed in tens of
milliseconds, consistent with block of channel currents. Caffeine (20 mM) did not reduce currents activated by exogenous
NMDA, indicating that caffeine block is specific to non-NMDA type glutamate receptors.
Conclusions/Significance: Caffeine-induced inhibition of mEPSC amplitude occurs through postsynaptic block of non-
NMDA type ionotropic glutamate receptors. Caffeine thus has both pre and postsynaptic sites of action at excitatory
synapses.
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Introduction
The popular stimulant, caffeine, modulates intracellular calcium
signaling in many cell types [1]. The ryanodine receptor (RyR) is
one target for caffeine. Millimolar concentrations (5–20 mM) of
caffeine stimulate calcium-induced calcium release (CICR) from
intracellular stores. Caffeine sensitizes RyR so that low nanomolar
concentrations of cytosolic calcium activate RyR leading to
calcium efflux into the cytoplasm [2]. In addition, caffeine also
acts on the other primary endoplasmic reticulum calcium release
channel, the inositol triphosphate receptor (IP3R), over the same
concentration range. Caffeine inhibited IP3R single-channel
openings with a half-maximal inhibition of 1.6 mM [3].
Therefore, depending on the relative densities of RyR and IP3R
in a particular cell, caffeine can either stimulate or block calcium
release from intracellular stores.
Caffeine has been used extensively to study calcium signaling in
neurons. Caffeine increases spontaneous glutamate release from
nerve terminals [4] and can induce presynaptic long-term
potentiation [5]. Synaptically activated AMPA receptor-mediated
CICR has also been described using caffeine [6].
Here, we demonstrate that caffeine decreases the size of
miniature excitatory postsynaptic currents (mEPSCs) recorded
from neocortical neurons by directly inhibiting postsynaptic
glutamate receptor currents. Consistent with other reports, we
also demonstrate an increase in mEPSC frequency indicating a
caffeine-induced presynaptic increase in glutamate release. Thus,
caffeine modulation of glutamatergic transmission involves both
pre and postsynaptic targets.
Results
Caffeine decreases mEPSC size in neocortical neurons
We examined the effects of caffeine (20 mM) on mEPSCs
recorded from neocortical neurons. Sodium channels were
blocked by tetrodotoxin (TTX) and spontaneous synaptic events
recorded at 270 mV. Caffeine was applied for 300 seconds. The
amplitude of mEPSCs decreased during the first 100 seconds of
caffeine application (Fig. 1A). The insets show representative
mEPSCs from the beginning and end of their respective traces
on an expanded time scale. The inhibition of mEPSC amplitude
was reversible (Fig. 1A). Amplitude histograms of all events
during 200 seconds of recording directly before caffeine
application and all events recorded during the last 200 seconds
of caffeine application confirmed this inhibition (Fig. 1B).
Average mEPSC amplitude is shown for seven cells before,
during, and after caffeine application (Fig. 1C). Average mEPSC
amplitude was 27.662.3 pA before and 15.761.0 pA during
caffeine application (P,0.001; n=7), demonstrating a 4364%
inhibition by caffeine. Miniature EPSC amplitude was reversibly
decreased by caffeine in all seven cells. Fig. 1D shows average
normalized diary plots of mEPSC frequency (top) and amplitude
(bottom) for seven cells. Caffeine increased mEPSC frequency in
all seven cells, consistent with previous work [4]. The increase in
mEPSC frequency was slower than the decrease in amplitude,
suggesting different sites of action. These data confirm that
caffeine increases mEPSC frequency in neocortical neurons, and
demonstrate a reduction in mEPSC amplitude not previously
described.
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We next asked whether caffeine exerted its effects on mEPSC
amplitude by a presynaptic or postsynaptic mechanism. We
applied glutamate (1 mM) to test for a direct postsynaptic effect of
caffeine on glutamate-activated currents (Iglu). Glutamate was
applied with a piezoelectric-controlled perfusion device to neurons
voltage-clamped at 270 mV. Glutamate was applied for 100 mil-
liseconds and co-application with caffeine reversibly decreased
peak Iglu amplitude (Fig. 2A). In these experiments glutamate
applications were made after perfusion with caffeine containing
solutions for .30 seconds (top 20 mM and bottom 50 mM). Bar
graphs show the average results from glutamate application in the
presence of 20 mM caffeine (Fig. 2B). Glutamate-activated
currents were 3.7960.71 nA and reduced to1.6360.35 nA in
the presence of caffeine (n=7; P=0.002). Currents recovered after
caffeine wash to 3.8460.72 nA (P=0.10 compared to control).
Thus, caffeine (20 mM) reversibly reduced the magnitude of Iglu
by 5765%. The action of caffeine was dose-dependent (Fig. 2C).
Inhibition of Iglu by caffeine increased during the application
(scaled traces, Fig. 2A). Consequently the steady state concentra-
tion-effect relationship was left-shifted relative to that for peak
glutamate-activated currents (Fig. 2C). Curves represent the
equation:
I=Imax~1= 1z caffeine ½  =IC50 ðÞ
n fg ð1Þ
where IC50 was 7 mM and 10 mM for inhibition of the steady-
state and peak glutamate-activated currents, respectively.
Caffeine blocks glutamate-activated currents rapidly
In previous experiments (Fig. 2) glutamate was applied after
.30 seconds of caffeine application. We next measured the
kinetics of caffeine block of glutamate-activated currents by
applying caffeine (20 mM) simultaneously with glutamate
(1 mM). Fig. 3 shows Iglu with and without caffeine. Each trace
is the average Iglu elicited by 5 applications of glutamate recorded
with a 0.33 Hz duty cycle. Traces did not change substantially
between applications. Caffeine block of Iglu developed during a
500 ms co-application of glutamate and caffeine. Inhibition is
absent during the initial rising phase of Iglu, partial during the
peak, and reaches steady-state by ,200 ms. The effect was
reversible. The time course of caffeine block was quantified by
dividing the glutamate-activated current in the presence of caffeine
(Icaff) by the previous current elicited by glutamate alone. This
ratio (Icaff/Iglu) is plotted as a function of time for the
Figure 1. Caffeine reversibly decreases mEPSC amplitude. (A) Recording of mEPSCs in whole-cell voltage-clamp in the presence of TTX
(1 mM). Caffeine (20 mM) caused a clear reversible decrease in mEPSC size. The fast rise and exponential fall of synaptic currents was clear throughout
recording (insets). (B) Amplitude histograms of events in A 200 seconds immediately before caffeine (black) and during the last 200 seconds of
caffeine application (blue). (C) Average mEPSC amplitudes for seven cells before (black), during (blue), and after (red) caffeine application. (D)
Normalized average diary plots of mEPSC frequency (top) and amplitude (bottom), n=7. Bin size=10 seconds. Each point is normalized to the
average of 200 seconds of data recorded before drug application.
doi:10.1371/journal.pone.0003155.g001
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mate application (black, Fig. 3 inset). This decay was fit with a
single exponential function with a time constant of 57 ms. The
average time constant for inhibition was 52612 ms (n=3). The
dashed line represents the steady-state inhibition of Iglu and crosses
the y-axis at 0.27 for this recording. The average steady-state value
for Icaff/Iglu was 0.2960.02, which agrees well with the inhibition
of steady-state Iglu in the presence of steady-state caffeine
concentration (0.28, Fig. 2C). Thus, caffeine action is rapid, and
Iglu blockade develops during glutamate application (Fig. 2). These
data demonstrate that caffeine inhibits glutamate receptor current
by a fast mechanism, consistent with simple channel block but not
consistent with more complex forms of regulation such as changes
in receptor expression.
Caffeine-mediated block of glutamate receptor currents
is specific for non-NMDA type ionotropic glutamate
receptors
Both AMPA and NMDA-activated currents are activated by
glutamate application to neocortical neurons. The mEPSCs in
neocortical neurons were blocked by CNQX and thus are
mediated by non-NMDA receptors (data not shown). To test if
caffeine also blocked NMDA-activated currents we applied
NMDA (20 mM) in the absence and presence of caffeine.
NMDA-mediated currents (INMDA) were evoked in the presence
of 2.5 mM glycine and in the absence of extracellular magnesium
every 2 minutes. INMDA were minimally affected by the applica-
tion of 20 mM caffeine (Fig. 4A). Average data for NMDA
application to six cells is shown in Fig. 4B. INMDA was
3.0960.59 nA before and 2.9260.56 nA in the presence of
20 mM caffeine (n=6; P=0.21). After caffeine wash, INMDA
recovered to 3.1860.64 (P=0.39 compared to control). In
addition, glutamate (200 mM) was applied to neurons in the
presence of CNQX (25 mM) and glycine (2.5 mM) in the absence
of magnesium. These NMDA receptor-mediated currents did not
change in the presence of 20 mM caffeine (n=2, data not shown).
Our results confirm that caffeine-mediated inhibition of mEPSC
amplitude and Iglu are not mediated by NMDA receptors.
Discussion
Caffeine modulates intracellular calcium and can stimulate
neurotransmitter release from nerve terminals [4]. We determined
that the frequency of spontaneous transmitter release was
increased in recordings from neocortical neurons. Surprisingly,
caffeine also produced an accompanying decrease in the
amplitude of quantal events. Caffeine inhibited currents activated
by direct application of glutamate to cortical neurons, confirming
a postsynaptic site of action. This unexpected form of inhibition
developed over tens of milliseconds and was independent of
NMDA receptors, consistent with non-NMDA receptor block.
Figure 2. Caffeine inhibits postsynaptic glutamate-activated currents (Iglu). (A) Glutamate (1 mM) was applied to neurons in whole-cell
voltage clamp in the presence of TTX. Individual traces from a representative recording of Iglu before (black), during (blue) and after (red) the addition
of 20 mM (top) or 50 mM (bottom) caffeine. (B) Average peak Iglu for 5 consecutive applications of glutamate (3 second interval) before, during, and
after 20 mM caffeine application. (C) Normalized peak (open circles) and steady-state (closed triangles) Iglu for 1.25, 5, 20, and 50 mM caffeine. Values
normalized to average peak or steady-state Iglu before caffeine for each recording. Curves represent Equation 1.
doi:10.1371/journal.pone.0003155.g002
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We found that caffeine increased the frequency of mEPSCs,
consistent with a previous report [4] (Fig. 1). A change in the
frequency of spontaneous neurotransmitter release events is a clear
indicator of a presynaptic change in the probability of vesicle
fusion. A change in quantal size could result from either pre or
postsynaptic mechanisms [7] – variation in mEPSC size was
recently shown to depend on vesicular glutamate concentration
[8]. We postulated that caffeine-mediated changes in mEPSC
amplitude and frequency (Fig. 1) both resulted from presynaptic
modulation. However, the distinct time courses of both changes
pointed to different mechanisms of action (Fig. 1D). Caffeine
inhibited currents activated by exogenous glutamate and quantal
events by a similar amount confirming a postsynaptic action. We
postulated two mechanisms by which caffeine mediated these
effects: by directly blocking the glutamate activated channels or by
reducing postsynaptic glutamate receptor density. However,
Figure 3. Caffeine rapidly inhibits glutamate-activated currents. After control recording of Iglu (black), glutamate was applied simultaneously
with 20 mM caffeine (Icaff; blue). Recovery is shown in red. Traces are averages of 5 consecutive applications of glutamate or glutamate plus caffeine
(3 second interval). Inset: Icaff/Iglu plotted versus time for representative cell (black) to show time course of inhibition of Iglu by caffeine. Calculation
was started 10 ms after start of glutamate application, shortly before peak of Iglu. Decay was fit to a single exponential (red curve). Steady-state
inhibition of Iglu (dashed line) is 0.27 for this recording.
doi:10.1371/journal.pone.0003155.g003
Figure 4. Caffeine does not inhibit postsynaptic NMDA-receptor mediated currents (INMDA). (A) NMDA (20 mM) was applied to neurons in
whole-cell voltage clamp in the presence of glycine and TTX, and zero extracellular Mg
2+. Individual traces from a representative recording of INMDA
before (black), during (blue) and after (red) the addition of 20 mM caffeine. (B) Average peak INMDA for single applications of NMDA before, during,
and after 20 mM caffeine application (120 second interval).
doi:10.1371/journal.pone.0003155.g004
Caffeine Inhibits Glutamate
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receptors (AMPARs) is probably too slow to explain this effect
since it occurs over tens of seconds[9]. In contrast, caffeine
mediated block of Iglu was rapid, developing in tens of milliseconds
(Fig. 3), or ,1000 times faster than endocytosis of receptors. These
data support the proposal that caffeine decreases mEPSC
amplitude by direct postsynaptic block of glutamate-activated
channels.
Caffeine mediated inhibition of mEPSCs was slightly smaller
than inhibition of peak glutamate-activated currents (43% vs.
57%, respectively). While this observation could be due to
extrasynaptic glutamate receptors being more sensitive to caffeine,
we feel it more likely reflects a sampling bias caused by selecting
mEPSCs based on an amplitude threshold. Our use of a threshold
means that proportionately more of the smaller mEPSCs in
caffeine failed to reach detection reducing the amount of caffeine-
mediated inhibition. This effect is evident in the mEPSC
amplitude histogram (Fig. 1B).
Caffeine modulation of glutamate signaling
Recently it was reported that caffeine blocks CICR triggered by
calcium influx through calcium permeable AMPARs [6]. Gluta-
mate or AMPA-induced increases in intracellular calcium concen-
tration were decreased in the presence of caffeine. This result was
interpreted as a caffeine-induced depletion of ryanodine-sensitive
calcium store calcium. Our results provide an additional interpre-
tation to their data: that caffeine directly blocks AMPAR-mediated
calcium currents responsible for CICR. Morton-Jones et al. provide
strong additional evidence, however, that glutamate-activated
intracellular calcium increases are mediated by CICR by blocking
them with the RyR blocker ryanodine.
In contrast to our findings, caffeine (10 mM) has been reported to
increase mEPSC amplitude in recordings from barrel cortex slices
[10]. The authors showed an increase in median mEPSC amplitude
from ,2.5 to 4.5 pA in the presence of caffeine. These small
mEPSCs would have been difficult to distinguish from baseline
fluctuations by automated analysis. In fact, the median event size
represented only 3–4 channel openings (using AMPA-activated
channel conductance,10 pS [11] and 70 mV driving voltage). It is
possible that these small events reflected baseline channel activity
that was mischaracterized as representing mEPSCs. If caffeine
application increased mEPSC frequency, and these mEPSCs were
larger than the baseline events, this would have resulted in an
apparent increase in mEPSC size. The mEPSCs we recorded were
much larger (19 to 39 pA; Fig. 1C) and clearly distinguished from
baseline activity since our detection threshold was ,5 pA. Thus the
increased signal-noise ratio in our experiments provides strong
evidence that caffeine inhibits mEPSC amplitude.
Caffeine actions in vivo
The widespread use of caffeine begs the question whether
glutamate receptor blockade may occur in humans. Caffeine
concentration in blood reaches only 60 mM after ingestion of the
equivalent of 4 cups of coffee [12]. The blood-brain barrier is
readily permeable to caffeine, so the concentration in the brain is
close to that in the blood [13]. Since caffeine inhibits glutamate
receptors with an apparent IC50 of ,10 mM (Fig. 2C, equation 1)
we suggest that ingested caffeine is unlikely to have any effect on
ionotropic glutamate receptors. Instead caffeine likely produces
stimulatory effects in humans through its potent antagonism of the
adenosine receptor (IC50 50–100 mM) [14]. Adenosine-mediated
activation of A1 adenosine receptors on nerve terminals impairs
synaptic transmission by inhibiting voltage-gated calcium channels
[15]. Thus, one mechanism by which normal physiological levels
of caffeine stimulates synaptic transmission is by inhibiting the
adenosine binding, relieving the inhibition of voltage-gated
calcium channels and producing higher probability of release of
neurotransmitter.
However, it is possible that excess use of caffeine tablets may lead
to brain levels at which glutamate-activated channel modulation
occurs. For instance, acute caffeine toxicity has been blamed for the
death of a 22-yr old woman who experienced serum caffeine levels
of ,8 mM following overdose with diet pills [16].
Conclusions
We have demonstrated a novel action of caffeine on excitatory
transmission in the central nervous system. We show that, in
addition to increasing the probability of spontaneous release of
neurotransmitter, caffeine inhibits postsynaptic AMPA-type glu-
tamate-activated channels. This occurred at caffeine concentra-
tions regularly used for studying intracellular calcium signaling.
Furthermore, our results are consistent with the hypothesis that
caffeine-mediated glutamate receptor blockade may only occur
under extreme conditions of toxicity.
Methods
Neuronal preparation
Neocortical neurons were isolated from P1-2 mouse pups. All
animal procedures were approved by OHSU I.A.C.U.C. in
accordance with the U.S. Public Health Service Policy on
Humane Care and Use of Laboratory Animals and the N.I.H.
Guide for the Care and Use of Laboratory Animals. Animals were
deeply anesthetized with isoflurane before decapitation and
removal of cortices. Cortices were then incubated in trypsin and
DNAse and then dissociated with a heat polished pipette.
Dispersed cells were cultured in MEM plus 5% FBS on glass
coverslips. ARAC (4 mM final concentration) was added 48 hours
after plating to limit glial division. Cells were used after at least 14
days in culture. Eight different neuronal culture preparations from
eight different mice were used for these experiments.
Electrophysiological recordings
Cells were visualized with an Olympus IX70 inverted
microscope. Recordings were made in whole-cell voltage clamp.
Holding potential was 275 mV. Extracellular solutions contained
(in mM) 150 NaCl, 4 KCl, 10 HEPES, 10 glucose, pH 7.35. NaCl
was substituted with either caffeine or sucrose to maintain
osmolarity. Recordings of mEPSCs were made in the presence
of TTX (1 mM) and bicuculline (10 mM) to block Na channels and
GABA-activated currents, respectively. TTX was also used during
glutamate application experiments. Intracellular solution consisted
of (in mM) 140 K
+ gluconate, 9 EGTA, 10 HEPES, 4 MgCl2,1
CaCl2, 4 NaATP, 0.3 NaGTP, 1.4 phosphocreatine, pH 7.2.
Electrode tips had final resistances of 3–6 MV. Currents were
recorded with a HEKA EPC9/2 amplifier. For mEPSC
recordings, currents were filtered at 1 kHz using a Bessel filter
and sampled at 10 kHz. For recordings of currents evoked by
applied glutamate, currents were filtered at 3 kHz and sampled at
20 kHz. Series resistance (Rs) was monitored, and recordings were
discarded if Rs changed by more than 10% during recording. For
glutamate-application experiments, Rs was usually compensated
by ,70%. We estimate that in a typical experiment our inhibition
of Iglu by caffeine (20 mM) is underestimated by ,9% [17].
Solution application
For mEPSC recordings, solutions were bath applied through a
perfusion pipette placed ,1 mm from the patch pipette tip. Local
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open-tip conductance changes. For fast application of glutamate, a
custom-built piezoelectric-driven perfusion system was used. A
piece of theta glass containing four small perfusion tubes (two in
each barrel) was mounted to a piezoelectric bimorph (Piezo
Systems, Inc., product # T234-A4CL-203X) which was mounted
to a plastic rod controlled by a micromanipulator. A high-voltage
stimulus isolator (World Precision Instruments, Sarasota, Florida,
product # A360D or A365D) was used to stimulate the bimorph.
A TTL pulse supplied by one of the digital-to-analog outputs on
the EPC9/2 was used to drive the stimulus isolator. Theta glass
was pulled and broken to a tip diameter of approximately
300 microns. A smooth break of barrels and septum was achieved
to minimize solution mixing at tip. During a whole-cell voltage
clamp recording, the perfusion tip was located so that zero steady-
state glutamate activated current was detected. Stimulation of the
bimorph moved the solution interface across the neuron. Time of
perfusion change to whole neuron was estimated with open-tip
conductance measurements with electrode tip at a distance from
the theta tube characteristic of a cell soma. Total solution change
in this configuration occurred in ,5 ms.
Analysis
Data were acquired on a PIII computer and analyzed with
IgorPro (Wavemetrics, Lake Oswego, OR) and Minianalysis
(Syanptosoft, Decatur, GA) software. For all experiments,
statistical significance was determined using Student’s t-test as
appropriate (Microsoft EXCEL, Richmond, WA). Averaged data
values are reported as means6SEM.
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